Research paper
Interventions for central serous chorioretinopathy: a network meta-analysis.
Study answer
What this study found
Overall, the review did not find strong enough evidence to recommend one treatment over another for central serous chorioretinopathy. Evidence quality was low or very low, and the trials were too small and heterogeneous to support robust comparisons. Observation remained a reasonable initial strategy for acute CSC, and the data were insufficient to make definitive choices among interventions such as photodynamic therapy, laser therapies, anti-VEGF agents, or systemic/oral medications. In the antioxidant trials, effects on vision and retinal thickness were small or imprecise, with limited and…
- Study & population
- Network meta-analysis of randomized trials in adults with central serous chorioretinopathy diagnosed by optical coherence tomography or fluorescein angiography.
- Intervention
- High-dose antioxidant supplementation was one of the interventions assessed in this network meta-analysis of central serous chorioretinopathy, typically compared with placebo.
- Key limitation
- The evidence base was limited by small sample sizes, substantial heterogeneity, and low or very low certainty.
View source
Open PDFOriginal abstract
BACKGROUND Central serous chorioretinopathy (CSC) is characterized by serous detachment of the neural retina with dysfunction of the choroid and retinal pigment epithelium (RPE). The effects on the retina are usually self limited, although some peopl…